Skip to content

Chase Cardiovascular Patch Kit

by Chase Medical, Inc. 3 variants

510(k) K020132

Chase Cardiovascular Patch Kit is a medical device (FDA Class II; FDA product code DXZ, Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene) made by Chase Medical, Inc., cleared under FDA 510(k) K020132 on 26 Feb 2002, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK020132 Date26 Feb 2002ClearedStatusActive

Official records

From the FDA record

Received by the FDA
15 Jan 2002
FDA decision
26 Feb 2002 (Substantially Equivalent)
FDA review time
42 days from receipt to decision
Public document
510(k) statement on file with the FDA

From the FDA 510(k) record K020132 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
DXZ
Device class
Class II
Regulation
21 CFR Part 870.3470
Advisory committee
Cardiovascular
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code DXZ (Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene).

Other devices from Chase Medical, Inc.

See all devices from Chase Medical, Inc. →